• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性健康倡议关于绝经后激素治疗与心血管疾病的观察性研究和临床试验数据的综合分析。

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.

作者信息

Prentice Ross L, Langer Robert D, Stefanick Marcia L, Howard Barbara V, Pettinger Mary, Anderson Garnet L, Barad David, Curb J David, Kotchen Jane, Kuller Lewis, Limacher Marian, Wactawski-Wende Jean

机构信息

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.

出版信息

Am J Epidemiol. 2006 Apr 1;163(7):589-99. doi: 10.1093/aje/kwj079. Epub 2006 Feb 16.

DOI:10.1093/aje/kwj079
PMID:16484450
Abstract

Circumstances in which both randomized controlled trial and observational study data are available provide an important opportunity to identify biases and improve study design and analysis procedures. In addition, joint analyses of data from the two sources can extend clinical trial findings. The US Women's Health Initiative includes randomized controlled trials of use of estrogen by posthysterectomy women and of estrogen plus progestin by women with a uterus, along with corresponding observational study components. In this paper, for coronary heart disease, stroke, and venous thromboembolism, results are first presented from joint analysis of estrogen clinical trial and observational study data to show that residual bias patterns are similar to those previously reported for estrogen plus progestin. These findings support certain combined analyses of the observational data on estrogen and the estrogen plus progestin clinical trial and observational study data to give adjusted observational study estimates of estrogen treatment effects. The resulting treatment effect estimates are compared with corresponding clinical trial estimates, and parallel analyses are also presented for estrogen plus progestin. An application to postmenopausal hormone treatment effects on coronary heart disease among younger women is also provided.

摘要

随机对照试验和观察性研究数据均可得的情况为识别偏倚以及改进研究设计和分析程序提供了重要契机。此外,对来自这两种来源的数据进行联合分析能够拓展临床试验结果。美国妇女健康倡议包括对子宫切除术后女性使用雌激素以及有子宫女性使用雌激素加孕激素的随机对照试验,以及相应的观察性研究部分。在本文中,针对冠心病、中风和静脉血栓栓塞,首先呈现雌激素临床试验和观察性研究数据联合分析的结果,以表明残留偏倚模式与先前报道的雌激素加孕激素的偏倚模式相似。这些发现支持对雌激素观察性数据以及雌激素加孕激素临床试验和观察性研究数据进行某些联合分析,以得出雌激素治疗效果的经调整观察性研究估计值。将所得的治疗效果估计值与相应的临床试验估计值进行比较,同时也对雌激素加孕激素进行平行分析。还提供了绝经后激素治疗对年轻女性冠心病影响的应用情况。

相似文献

1
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.女性健康倡议关于绝经后激素治疗与心血管疾病的观察性研究和临床试验数据的综合分析。
Am J Epidemiol. 2006 Apr 1;163(7):589-99. doi: 10.1093/aje/kwj079. Epub 2006 Feb 16.
2
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.绝经后激素联合治疗与心血管疾病:致力于解决观察性研究与妇女健康倡议临床试验之间的差异
Am J Epidemiol. 2005 Sep 1;162(5):404-14. doi: 10.1093/aje/kwi223. Epub 2005 Jul 20.
3
Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.绝经后女性中雌激素加孕激素的使用与乳腺X线密度:妇女健康倡议随机试验
J Natl Cancer Inst. 2005 Sep 21;97(18):1366-76. doi: 10.1093/jnci/dji279.
4
The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.醋酸甲羟孕酮对雌激素依赖性风险和益处的影响——解读女性健康倡议结果的尝试。
Gynecol Endocrinol. 2006 Jun;22(6):303-17. doi: 10.1080/09513590600717368.
5
A comparative review of the risks and benefits of hormone replacement therapy regimens.激素替代疗法方案的风险与益处的比较性综述。
Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. doi: 10.1016/j.ajog.2003.09.033.
6
Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.雌激素加孕激素疗法的风险:妇女健康倡议随机对照试验结果的敏感性分析
Climacteric. 2003 Dec;6(4):302-10; discussion 310-3.
7
The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.妇女健康倡议雌激素加孕激素试验:研究及其对我们临床实践的影响。
J Am Osteopath Assoc. 2003 Feb;103(2 Suppl 2):S3-5.
8
New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.迫切需要有关激素替代疗法的新证据,经皮绝经后激素疗法在风险和益处方面与口服激素疗法不同。
Maturitas. 2005 Sep 16;52(1):1-10. doi: 10.1016/j.maturitas.2005.05.003.
9
Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).非特异性胸痛女性的心血管风险(来自女性健康倡议激素试验)
Am J Cardiol. 2008 Sep 15;102(6):693-9. doi: 10.1016/j.amjcard.2007.12.044. Epub 2008 Jul 2.
10
Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.雌激素争议结束了吗?剖析妇女健康倡议研究:对证据的批判性评估。
Ann N Y Acad Sci. 2005 Jun;1052:43-56. doi: 10.1196/annals.1347.004.

引用本文的文献

1
The Future of Causal Inference.因果推断的未来。
Am J Epidemiol. 2022 Sep 28;191(10):1671-1676. doi: 10.1093/aje/kwac108.
2
Hormone replacement therapy in women with cancer and risk of cancer-specific mortality and cardiovascular disease: a protocol for a cohort study from Scotland and Wales.患有癌症的女性的激素替代疗法与癌症特异性死亡率和心血管疾病风险:来自苏格兰和威尔士的队列研究方案。
BMC Cancer. 2021 Mar 24;21(1):313. doi: 10.1186/s12885-021-08065-3.
3
A Review of Challenges and Opportunities in Machine Learning for Health.机器学习在健康领域的挑战与机遇综述。
AMIA Jt Summits Transl Sci Proc. 2020 May 30;2020:191-200. eCollection 2020.
4
Sex hormones and stroke: Beyond estrogens.性激素与卒中:不止雌激素。
Horm Behav. 2019 May;111:87-95. doi: 10.1016/j.yhbeh.2018.10.010. Epub 2018 Nov 20.
5
Stratified Probabilistic Bias Analysis for Body Mass Index-related Exposure Misclassification in Postmenopausal Women.绝经后妇女体重指数相关暴露错分类的分层概率偏差分析。
Epidemiology. 2018 Sep;29(5):604-613. doi: 10.1097/EDE.0000000000000863.
6
Non-health Care Facility Medication Errors Associated with Hormones and Hormone Antagonists in the United States.美国与激素及激素拮抗剂相关的非医疗机构用药错误
J Med Toxicol. 2017 Dec;13(4):293-302. doi: 10.1007/s13181-017-0630-8. Epub 2017 Sep 13.
7
Hormone replacement therapy reduces lipid oxidation directly at the arterial wall: A possible link to estrogens' cardioprotective effect through atherosclerosis prevention.激素替代疗法可直接降低动脉壁处的脂质氧化:这可能是雌激素通过预防动脉粥样硬化发挥心脏保护作用的一个联系。
J Midlife Health. 2017 Jan-Mar;8(1):11-16. doi: 10.4103/0976-7800.201967.
8
A Dormant Microbial Component in the Development of Preeclampsia.子痫前期发展过程中的一种潜伏微生物成分。
Front Med (Lausanne). 2016 Nov 29;3:60. doi: 10.3389/fmed.2016.00060. eCollection 2016.
9
Fibroid interventions: reducing symptoms today and tomorrow: extending generalizability by using a comprehensive cohort design with a randomized controlled trial.子宫肌瘤干预措施:减轻当下及未来症状:通过综合队列设计与随机对照试验扩大普遍性
Am J Obstet Gynecol. 2016 Sep;215(3):338.e1-338.e18. doi: 10.1016/j.ajog.2016.04.001. Epub 2016 Apr 9.
10
Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder.利用患者自我报告研究重度抑郁症治疗效果的异质性。
Epidemiol Psychiatr Sci. 2017 Feb;26(1):22-36. doi: 10.1017/S2045796016000020. Epub 2016 Jan 26.